ATLASImmix Biopharma (IMMX) earnings date: Nov 6, 2026
Immix Biopharma (IMMX) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 6, 2026, after the close. Analysts expect EPS of -$0.18.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on IMMX
| Last price | $7.25 (-5.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.3% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Immix Biopharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Immix Biopharma reports on Nov 6, 2026. One email the day before, with ATLAS’s read on Immix Biopharma. You can switch it off at any time.
Alert me before IMMX reportsFree to start. Creating an account takes under a minute.
Notify me when Immix Biopharma reports
Track IMMX free Add Immix Biopharma to a free ATLAS watchlist and see its next report date in one place.
IMMX earnings at a glance
| Next report (confirmed) | Fri, Nov 6, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.18 |
| Last report | Aug 7, 2026 · In line |
| Beat rate (last 3 reports) | 2 of 3 (67%) |
| Average EPS surprise | +18.8% |
| Average move around a report | ±4.3% (last 3) |
| Sector | Healthcare · Biotechnology |
Immix Biopharma earnings history: last 3 reports
Immix Biopharma last reported on Aug 7, 2026: EPS of -$0.18 against an estimate of -$0.18 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 7, 2026 | -$0.18 | -$0.18 | 0.0% | In line | +0.7% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | +4.3% |
| Apr 30, 2026 | $2.03 | $2.68 | +32.0% | Beat | +7.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for IMMX
See the fair value, the probability range and the earnings history of Immix Biopharma on its ATLAS page.
Immix Biopharma (IMMX) stock analysisPlans from €3.99 a month.
Immix Biopharma earnings: frequently asked questions
When does Immix Biopharma (IMMX) report earnings?
Immix Biopharma is scheduled to report on Friday, November 6, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for IMMX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.18 per share (USD). Estimates can change before the report.
How often does IMMX beat earnings estimates?
Of its last 3 reports with a recorded result, Immix Biopharma beat the EPS estimate 2 times; the average surprise was +18.8%. Past results do not predict the next one.
How much does IMMX move around earnings?
Over its last 3 reports the stock moved an average of 4.3% (absolute, from the close before the report day to the close after it), and finished higher 3 of 3 times.
Did Immix Biopharma beat earnings estimates last quarter?
Immix Biopharma last reported on Aug 7, 2026: EPS of -$0.18 against an estimate of -$0.18 (0.0% surprise), in line with the estimate.
How much does IMMX usually move in a day?
On a normal trading day the ATLAS model puts IMMX’s one-day range at about ±4.3%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 6, 2026
Educational information, not investment advice. Disclaimer